It’s been an awesome September for CBI at UD! The passion and knowledge of the seminar speakers this month both expanded the understanding of relevant research and provided a time for important connection. Thank you; to PhD candidate Stephen Hyland for leading off the semester with an update on his research in Dr Grimes’ lab, “Investigation of MurJ as a Potential Antibiotic Target through Utilization of Electrophilic MurNAc Derivatives”; to Dr. Salil Lachke, UD Professor in Biological Sciences, who shared his research on “Post-transcriptional Gene Regulatory Networks in Eye Development and Disease”; to Dr. Jim Melnyck, a current PostDoc in UCSF, who spoke of “Targeting a Splicing-mediated Resistance Mechanism in Prostate Cancer”; to Dr. Yimon Aye, Head of Laboratory of electrophiles and genome operation (LEAGO), at at ISIC, EPFL, who “visited” us from Switzerland, and spoke of her research “Illuminating how ephemeral electrophiles rewire cell decision-making processes”; and to Dr. Avi Schroeder, Head of the Laboratory for Targeted Drug Delivery and Personalized Medicine at Technion in beautiful Haifa, Israel, who ignited the enthusiasm of all with his talk on “Barcoded Nanoparticles for Precision Cancer Medicine: Effects of tumor type and patient sex on anticancer efficacy”. CBI students enjoyed time with both Drs. Aye and Schroeder where they could ask questions and learn more about their labs. 

The value of connection cannot be emphasized enough during this pandemic, and it warms all of our hearts to enjoy the company of very busy people who graciously give their time and energy to be with us. It certainly makes a difference.

Be Well,

Catherine